- Home
- Publications
- Publication Search
- Publication Details
Title
Oral ketamine may offer a solution to the ketamine conundrum
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1007/s00213-023-06480-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral ketamine for depression: An updated systematic review
- (2023) Shakila Meshkat et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
- (2023) Giacomo d'Andrea et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment response with ketamine in chronic suicidality: An open label functional connectivity study
- (2023) Adem T. Can et al. JOURNAL OF AFFECTIVE DISORDERS
- Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing
- (2022) Jennifer Swainson et al. CNS DRUGS
- A review of potential neuropathological changes associated with ketamine
- (2022) Danica Nogo et al. Expert Opinion On Drug Safety
- Stress, mental disorder and ketamine as a novel, rapid acting treatment
- (2022) Megan Dutton et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
- (2022) Christina Driver et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans
- (2022) J. F. Nottage et al. PSYCHOPHARMACOLOGY
- Electrophysiological phenotypes of suicidality predict prolonged response to oral ketamine treatment
- (2022) Adem T. Can et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
- (2021) Torsten Passie et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
- (2021) Jason Ng et al. PSYCHOPHARMACOLOGY
- Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
- (2021) Adem T. Can et al. Translational Psychiatry
- Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
- (2021) Ioline D. Henter et al. CNS DRUGS
- Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
- (2021) Vesna Lazarevic et al. MOLECULAR PSYCHIATRY
- Glutamate modulators and beyond: A neuroscience revolution in the making
- (2021) Carlos A. Zarate EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Six-week oral ketamine treatment for chronic suicidality is associated with increased grey matter volume
- (2021) Cyrana C. Gallay et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
- (2020) Jessica R. Gilbert et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- (2R,6R)-Hydroxynorketamine (HNK) plasma level predicts poor antidepressant response: is this the end of the HNK pipeline?
- (2020) Chadi G. Abdallah NEUROPSYCHOPHARMACOLOGY
- Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
- (2020) Cristan A. Farmer et al. NEUROPSYCHOPHARMACOLOGY
- Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial
- (2020) Michael F. Grunebaum et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- Influence of formulation and route of administration on ketamine’s safety and tolerability: systematic review
- (2020) Paul Glue et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
- (2019) Gihyun Yoon et al. JAMA Psychiatry
- The Role of NMDA Receptors in Alzheimer’s Disease
- (2019) Jinping Liu et al. Frontiers in Neuroscience
- Ketamine: A Paradigm Shift for Depression Research and Treatment
- (2019) John H. Krystal et al. NEURON
- Esketamine: a glimmer of hope in treatment-resistant depression
- (2019) Upinder Kaur et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine applications beyond anesthesia – A literature review
- (2019) Agata Nowacka et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ketamine metabolite pilot study in a suicidal depression trial
- (2019) Michael F. Grunebaum et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- Can a Framework Be Established for the Safe Use of Ketamine?
- (2018) Robert Freedman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression
- (2018) Ming-Fen Ho et al. BIOCHEMICAL PHARMACOLOGY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug
- (2018) Agnieszka Pałucha-Poniewiera Pharmacological Reports
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
- (2018) Yan Yang et al. NATURE
- Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials
- (2017) Elizabeth D. Ballard et al. JOURNAL OF AFFECTIVE DISORDERS
- Oral Ketamine in Treatment-Resistant Depression
- (2017) Maryam I. Al Shirawi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
- (2017) C A Zarate et al. MOLECULAR PSYCHIATRY
- Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
- (2017) Jerome H Taylor et al. NEUROPSYCHOPHARMACOLOGY
- Oral Ketamine for Acute Pain Management After Amputation Surgery
- (2017) Asokumar Buvanendran et al. PAIN MEDICINE
- Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study
- (2017) John Hartberg et al. PSYCHOPHARMACOLOGY
- Chronic Ketamine Exposure Causes White Matter Microstructural Abnormalities in Adolescent Cynomolgus Monkeys
- (2017) Qi Li et al. Frontiers in Neuroscience
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment
- (2016) Kathryn M. Schak et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
- (2016) Marko A. Peltoniemi et al. CLINICAL PHARMACOKINETICS
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- CYP2B6*6allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects
- (2015) Yibai Li et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sex differences in glutamate receptor gene expression in major depression and suicide
- (2015) A L Gray et al. MOLECULAR PSYCHIATRY
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- Oral ketamine augmentation for chronic suicidality in treatment-resistant depression
- (2014) Angelo De Gioannis et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S-Ketamine and Less on Intravenous S-Ketamine
- (2014) Marko A. Peltoniemi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients
- (2014) F. Marchetti et al. EUROPEAN JOURNAL OF PAIN
- Ketamine administration in depressive disorders: a systematic review and meta-analysis
- (2014) Guillaume Fond et al. PSYCHOPHARMACOLOGY
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- The absolute bioavailability of racemic ketamine from a novel sublingual formulation
- (2013) Paul Rolan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
- (2013) Georges Mion et al. CNS Neuroscience & Therapeutics
- Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks
- (2013) Frank S. Menniti et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
- (2013) Diogo R. Lara et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
- (2013) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- On the Safety and Benefits of Repeated Intravenous Injections of Ketamine For Depression
- (2012) Pierre Blier et al. BIOLOGICAL PSYCHIATRY
- Oral Ketamine in the Palliative Care Setting
- (2011) Eliezer Soto et al. American Journal of Hospice & Palliative Medicine
- Depression and Pain
- (2011) E. Alfonso Romero-Sandoval ANESTHESIOLOGY
- Ketamine-associated lower urinary tract destruction: a new radiological challenge
- (2010) K. Mason et al. CLINICAL RADIOLOGY
- Use of oral ketamine in chronic pain management: A review
- (2009) Maren I. Blonk et al. EUROPEAN JOURNAL OF PAIN
- The destruction of the lower urinary tract by ketamine abuse: a new syndrome?
- (2008) Peggy Sau-Kwan Chu et al. BJU INTERNATIONAL
- Journey through the K-hole: Phenomenological aspects of ketamine use
- (2008) L. Muetzelfeldt et al. DRUG AND ALCOHOL DEPENDENCE
- Side Effects of Ketamine in the Long-Term Treatment of Neuropathic Pain
- (2008) Petr Cvrček PAIN MEDICINE
- Effects of norketamine enantiomers in rodent models of persistent pain
- (2008) J HOLTMANJR et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started